Parkinson's disease is a highly prevalent neurological disorder for which there is currently no cure. Therefore, the knowledge of risk factors as well as the development of new putative molecular targets is mandatory. In this sense, peripheral inflammation, especially the originated in the colon, is emerging as a predisposing factor for suffering this disease. We have largely studied the pleiotropic roles of galectin-3 in driving microglia-associated immune responses. However, studies aimed at elucidating the role of galectin-3 in peripheral inflammation in terms of microglia polarization are lacking. To achieve this, we have evaluated the effect of galectin-3 deletion in two different models of acute peripheral inflammation: intraperitonea...
Galectin-9 (Gal-9) is a crucial immunoregulatory mediator in the central nervous system. Microglial ...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and dem...
Parkinson’s disease is a highly prevalent neurological disorder for which there is currently no cure...
Parkinson’s disease is a highly prevalent neurological disorder for which there is currently no cure...
Background: Parkinson's disease (PD) is the most prevalent neurodegenerative motor disorder. The neu...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed differen...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed differen...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. There is a plethora of evidence to sugges...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
In addition to brain injury stroke patients often suffer gastrointestinal complications. Neuroimmune...
Parkinson’s Disease (PD) is a neurodegenerative and progressive disorder characterised by intracytop...
Galectin-9 (Gal-9) is a crucial immunoregulatory mediator in the central nervous system. Microglial ...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and dem...
Parkinson’s disease is a highly prevalent neurological disorder for which there is currently no cure...
Parkinson’s disease is a highly prevalent neurological disorder for which there is currently no cure...
Background: Parkinson's disease (PD) is the most prevalent neurodegenerative motor disorder. The neu...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed differen...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed differen...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. There is a plethora of evidence to sugges...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
In addition to brain injury stroke patients often suffer gastrointestinal complications. Neuroimmune...
Parkinson’s Disease (PD) is a neurodegenerative and progressive disorder characterised by intracytop...
Galectin-9 (Gal-9) is a crucial immunoregulatory mediator in the central nervous system. Microglial ...
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have ...
Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and dem...